Troy Edward Wilson, Director at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 5,000 shares at $9.10 ($46K) on 2026-09-14, disclosed to the SEC on 2026-09-16.
Scheduled sale ($46k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PBYI | SELL | 2026-06-15 | $78K | — | Filing → |
| KURA | SELL | 2025-09-29 | $655K | — | Filing → |
| KURA | BUY | 2025-09-09 | $820K | — | Filing → |